T cell mediated immunity to Mycobacterium tuberculosis

Current Opinion in Microbiology

Volumn 2, Issue 1, 1999, Pages 89-93

  Stenger, Steffen ^a   Modlin, Robert L ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; INTRACELLULAR KILLING; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; T LYMPHOCYTE; TUBERCULOSIS;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0033065522     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)80015-0     Document Type: Article

References (57)

1. Salo LW, Aufderheide AC, Buikstra J, Holcomb A Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc Natl Acad Sci USA. 91:1994;2091-2094.
2. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature [see comments]. JAMA. 271:1994;698-702.
3. Fine PE Variation in protection by BCG: implications of and for heterologous immunity [see comments]. Lancet. 346:1995;1339-1345. Published erratum appears in Lancet 1996, 347:340.
4. Bloom BR, Murray CJL Tuberculosis: commentary on a reemergent killer. Science. 257:1992;1055-1064.
5. Cisneros JR, Murray KM Corticosteroids in tuberculosis. Ann Pharmacother. 30:1996;1298-1303.
6. Daley CL, Small PM, Schecter GF, Schoolnik GK, Mcadam RA, Jacobs WR Jr., Hopewell PC An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length-polymorphisms. N Engl J Med. 326:1992;231-235.
7. Diperri G, Cruciani M, Danzi MC, Luzzati R, Dechecchi G, Malena M, Pizzighella S, Mazzi R, Solbiati M, Concia E Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 2:1989;1502-1504.
8. Dutt AK, Stead WW Tuberculosis in the elderly. Med Clin North Am. 77:1993;1353-1368.
9. + cells in the immunologic control of infection with Mycobacterium bovis strain Bacillus Calmette-Guerin in mice. J Immunol. 139:1987;2032-2037.
10. Orme IM The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol. 138:1987;293-298.
11. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 324:1991;1644-1650.
12. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Resp Dis. 148:1993;1292-1297.
13. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1993;1739-1742.
14. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR An essential role for interferon-gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 178:1993;2249-2254.
15. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J Exp Med. 178:1993;2243-2247.
16. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamso R, Levin M A mutation in the interferon-(gamma)-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 335:1996;1941-1949.
17. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova J Brief report: interferon-(gamma)-receptor deficiency in an infant with fatal bacille calmette-guerin infection. N Engl J Med. 335:1996;1956-1961.
18. Chan J, Xing Y, Magliozzo RS, Bloom BR Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 175:1992;1111-1122.
19. Macmicking JD, North RJ, Lacourse R, Mudgett JS, Shah KS, Nathan CF Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA. 94:1997;5243-5248.
20. + cytotoxic T cell clones. A novel potentially immunoregulatory T cell interaction in man. J Exp Med. 171:1990;2011-2024.
21. Lorgat F, Keraan MM, Lukey PT, Ress SR Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Resp Dis. 145:1992;418-423.
22. + alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J Immunol. 154:1995;1786-1796.
23. Oftung F, Borka E, Mustafa AS Mycobacterium tuberculosis reactive T cell clones from naturally converted PPD-positive healthy subjects: recognition of the M. tuberculosis 16-kDa antigen. FEMS Immunol Med Microbiol. 20:1998;319-325.
24. + cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol. 159:1997;290-297. This study suggests a significant contribution of CTLs in the local immune response to M. tuberculosis. Importantly the role of alveolar macrophages, the dominant cell population in the bronchoalveolar lavage, is analysed in this study.
25. + T cells can induce growth reduction, the exact mechanism, however, still needs to be uncovered.
26. + T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes. Am J Respir Crit Care Med. 158:1998;395-403.
27. + T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol. 160:1998;2374-2379.
28. + CTLs is described. Even though Fas ligation is induced artificially by recombinant FasL, this study suggests that CTLs can directly exert antimicrobial activity via this pathway.
29. North RJ Importance of thymus derived lymphocytes in cell-mediated immunity to infection. Cell Immunol. 7:1973;166-176.
30. + T-cells. Infect Immun. 55:1987;2037-2041.
31. Orme IM The kinetics of emergence and loss of mediator T-lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol. 138:1987;293-298.
32. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA. 89:1992;12013-12017.
33. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB Vaccination against tuberculosis by DNA injection. Nat Med. 2:1996;888-892.
34. Bonato VDL, Lima VMF, Tascon RE, Lowrie DB, Silva CL Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect Immun. 66:1998;169-175.
35. + T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 95:1998;270-275. This study introduces a novel approach to quantitate the number of antigen-specific, cytokine-secreting cells from freshly isolated blood lymphocytes. Clear evidence is provided for the presence of MHC class I restricted CTLs that recognize M. tuberculosis peptides in tuberculosis patients at a high frequency.
36. Mohagheghpour N, Gammon D, Kawamura LM, Van Vollenhoven A, Benike CJ, Engleman EG CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19 kDa lipoprotein. J Immunol. 161:1998;2400-2406.
37. + T cells lysed targets via the granule exocytosis pathway and simultaneously killed the intracellular bacteria.
38. Jackman RM, Stenger S, Lee A, Moody DB, Rogers RA, Niazi KR, Sugita M, Modlin RL, Peters PJ, Porcelli SA The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity. 8:1998;341-351.
39. Gong J, Stenger S, Zack JA, Jones BE, Bristol GC, Modlin RL, Morrissey PJ, Barnes PF Isolation of Mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. J Clin Invest. 101:1998;383-389.
40. + T-cells from tuberculosis patients recognizing M. tuberculosis infected targets is shown to be via a novel antigen presenting molecule, which remains to be defined.
41. + T lymphocytes in intracellular microbial infections. Immunol Today. 9:1988;168-174.
42. + T cell lines. Eur J Immunol. 18:1988;59-66.
43. + CTLs is shown to have antimycobacterial activity against extracellular and, in combination with the lytic molecule perforin, intracellular M. tubercuolsis.
44. + T cells requires the production of gamma interferon. Infect Immun. 66:1998;830-834.
45. Porcelli S The CD1 family: a third lineage of antigen presenting molecules. Adv Immunol. 59:1995;1-98.
46. Porcelli S, Morita CT, Brenner MB CD1b restricts the response of human CD4-8-T lymphocytes to a microbial antigen. Nature. 360:1992;593-597.
47. + T cells. Nature. 372:1994;691-694.
48. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Soriano T, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL CD1-restricted T cell recognition of microbial lipoglycans. Science. 269:1995;227-230.
49. Modlin RL, Pirmez C, Hofman FM, Torigian V, Uyemura K, Rea TH, Bloom BR, Brenner MB Lymphocytes bearing antigen-specific gamma/delta T-cell receptors in human infectious disease lesions. Nature. 339:1989;544-548.
50. Griffin JP, Harshan KV, Born WK, Orme IM Kinetics of accumulation of gamma delta receptor-bearing T lymphocytes in mice infected with live mycobacteria. Infect Immun. 59:1991;4263-4265.
51. Constant P, Davodeau F, Peyrat M, Poquet Y, Puzo G, Bonneville M, Fournie J Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science. 264:1994;267-270.
52. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR Natural and synthetic nonpeptide antigens recognized by human gamma/delta T cells. Nature. 375:1995;155-158.
53. Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SH Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol. 25:1995;2877-2881. Published erratum appears in Eur J Immunol 1995, 25:3525.
54. D'Souza CD, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol. 158:1997;1217-1221. Infection of mice with M. tuberculosis by the realistic pulmonary route indicated that γδ T cells are more critical for orchestrating the local cellular traffic than for determining the final outcome of disease.
55. Li B, Rossman MD, Imir T, Oner-Eyuboglu AF, Lee CW, Biancaniello R, Carding SR Disease-specific changes in gamma delta T cell repertoire and function in patients with pulmonary tuberculosis. J Immunol. 157:1996;4222-4229.
56. Manfredi AA, Heltai S, Rovere P, Sciorati C, Paolucci C, Galati G, Rugarli C, Vaiani R, Clementi E, Ferrarini M Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of gamma delta T cells to cause apoptosis. Eur J Immunol. 28:1998;1798-1806. It is demonstrated that engagement of the γδ TCR by mycobacterial antigens induces the upregulation of FasL, which in turn induces apoptosis of Fas-expressing cells. This suggests a regulatory role of γδ T cells in the early ganulomatous response to infection with M. tuberculosis.
57. Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of γδ T cells in patients with pulmonary tuberculosis. J Immunol. 161:1998;1558-1567. In vitro experiments demonstrate that M. tuberculosis antigens induce apoptosis of antigen-reactive T cells from tuberculosis patients by the interaction between Fas and FasL. This finding provides a model to explain the loss of γδ TCR positive T cells in the peripheral blood of tuberculosis patients in vivo.